Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony J Bench

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|June 9, 2007
A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathologyHongxiang Liu, Anthony J Bench, Chris M Bacon, et al.
Blood|August 2, 2003
Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosisSteffen Klippel, Elisabeth Strunck, Snezana Temerinac, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
A Polycythemia Vera Updated: Diagnosis, Pathobiology, and TreatmentThomas C. Pearson, Maria Messinezy, Nigel Westwood, et al.
British Journal of Haematology|February 16, 2010
Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosisElaine M Boyd, Anthony J Bench, Andrea Goday-Fernández, et al.
British Journal of Haematology|September 15, 2009
Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasmsLizz F Grimwade, Lisa Happerfield, Colin Tristram, et al.
Blood|May 16, 2002
Rescue of the lethal scl(-/-) phenotype by the human SCL locusAngus M Sinclair, Anthony J Bench, Adrian J C Bloor, et al.
Haematologica|September 26, 2008
Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disordersNasios Fourouclas, Juan Li, Daniel C Gilby, et al.
Lancet (London, England)|March 23, 2005
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersE Joanna Baxter, Linda M Scott, Peter J Campbell, et al.
Haematologica|December 18, 2009
Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?Göran Mattsson, Susan H Turner, Jacqueline Cordell, et al.
Blood|May 31, 2002
Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instabilityBrian J P Huntly, Anthony J Bench, Eric Delabesse, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|June 9, 2007
A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathologyHongxiang Liu, Anthony J Bench, Chris M Bacon, et al.
Blood|August 2, 2003
Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosisSteffen Klippel, Elisabeth Strunck, Snezana Temerinac, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
A Polycythemia Vera Updated: Diagnosis, Pathobiology, and TreatmentThomas C. Pearson, Maria Messinezy, Nigel Westwood, et al.
British Journal of Haematology|February 16, 2010
Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosisElaine M Boyd, Anthony J Bench, Andrea Goday-Fernández, et al.
British Journal of Haematology|September 15, 2009
Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasmsLizz F Grimwade, Lisa Happerfield, Colin Tristram, et al.
Blood|May 16, 2002
Rescue of the lethal scl(-/-) phenotype by the human SCL locusAngus M Sinclair, Anthony J Bench, Adrian J C Bloor, et al.
Haematologica|September 26, 2008
Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disordersNasios Fourouclas, Juan Li, Daniel C Gilby, et al.
Lancet (London, England)|March 23, 2005
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersE Joanna Baxter, Linda M Scott, Peter J Campbell, et al.
Haematologica|December 18, 2009
Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?Göran Mattsson, Susan H Turner, Jacqueline Cordell, et al.
Blood|May 31, 2002
Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instabilityBrian J P Huntly, Anthony J Bench, Eric Delabesse, et al.
Pageof 3